Vacuna nasal para enfermedad de Alzheimer comienza ensayos en humanos

After 20 years of studies, researchers will begin the first human trial for a nasal vaccine aimed at preventing and slowing Alzheimer’s disease. Sixteen participants at Boston’s Brigham and Women’s Hospital will receive two doses of the vaccine one week apart.

Fuente: Youtube